Anesthetic Techniques to Minimize PONV Following Ambulatory Surgery Webcast

Release date: May 23, 2013
Expiration date: May 23, 2014
Estimated time to complete activity: 1.0 hour

Faculty Presenters

Jeffrey G. Priest, MD
Medical Director
Central Utah Surgical Center
Provo, Utah

William E. Strong, MD
Central Utah Surgical Center
Provo, Utah

Program Overview

Postoperative nausea and vomiting (PONV) is a common adverse effect following ambulatory surgery and is a key factor contributing to patient distress and dissatisfaction. This Practitioner’s Edge program examines the burden of PONV and available strategies to minimize it following ambulatory surgery.

Measures for assessing specific patient risk factors that may affect the incidence of PONV are discussed as well as advances in the pharmacokinetic and pharmacodynamic profiles of anesthetic agents that may aid anesthesiologists in reducing PONV. With this knowledge, it may be possible to plan for risk factors that increase PONV incidence and prepare for real-time adjustments that may optimize patient recovery and satisfaction.

The overall goal of this program is to provide a thorough understanding of the mechanisms of PONV and the knowledge to implement strategies to reduce risk and overcome the burden of PONV following ambulatory surgery.

Target Audience

This educational activity has been designed to meet the educational needs of ambulatory anesthesiologists, residents in training, nurse anesthetists, and other healthcare providers interested in ambulatory anesthesia.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Review the burden of PONV with current anesthetic agents
  • Describe patient risk factors that affect the incidence of PONV
  • Discuss planned vs intraoperative adjustments to anesthetic agents to address these risks and minimize PONV

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Integrity Continuing Education, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty/planners reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Jeffrey G. Priest, MD
Consultant: Drug Enforcement Administration
Speakers Bureau: Mylan Specialty

Sean M. Gregory, PhD, and William E. Strong, MD, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Directions to the Learner

There are no fees for participating and receiving CME credit for this activity. During the period of May 23, 2013 through May 23, 2014, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.

Privacy Policy

When you participate in an online educational activity sponsored by Integrity CE, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and…(continued)



Minimum System Requirements

Windows 98, 2000, XP, 2003, Vista, and 7
Internet Explorer 6/7
Firefox 2
Mozilla 1.7 or higher
Netscape 8.1 or higher
Flash Player 10

Mac OS X 10.3, 10.4
Safari 1.3 (Mac OS 10.3)
Safari 2.0 or higher (Mac OS 10.4)
Firefox 2
Flash Player 10

Click here for more information on minimum system requirements.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Mylan Specialty, do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc. and Mylan Specialty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

continue to pretest


For questions about the accreditation of this program, please contact Integrity Continuing Education, Inc. at (888) 255-1009 or This email address is being protected from spambots. You need JavaScript enabled to view it. .

Sponsored by: integrity

Supported by an educational grant from:

mylan logo us 2 color

Anesthetic Techniques to Minimize PONV Following Ambulatory Surgery